Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.61 |
| ▸ | MAPT | P10636 | 4/20 | 0.61 |
| ▸ | MEN1 | O00255 | 4/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.61 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.61 |
| ▸ | POLB | P06746 | 1/20 | 0.57 |
| ▸ | GAA | P10253 | 3/20 | 0.56 |
| ▸ | ATM | Q13315 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.54 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.53 |
| ▸ | HPGD | P15428 | 3/20 | 0.53 |
| ▸ | RAB9A | P51151 | 3/20 | 0.53 |
| ▸ | HTT | P42858 | 2/20 | 0.53 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.53 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.53 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.53 |
| ▸ | MME | P08473 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3682694 | 0.89 | HTT (0.55) | ALDH1A1MAPTMEN1KMT2ARXFP1 | |
| SCHEMBL6864880 | 0.85 | ALDH1A1 (0.63) | ALDH1A1MAPTMEN1KMT2ARXFP1 | |
| SCHEMBL5662256 | 0.84 | SMN1; SMN2 (0.62) | ALDH1A1SMN1; SMN2HPGDRAB9AHTT | |
| SCHEMBL5662258 | 0.84 | SMN1; SMN2 (0.62) | ALDH1A1SMN1; SMN2HPGDRAB9AHTT | |
| SCHEMBL17466180 | 0.84 | HTT (0.65) | ALDH1A1MAPTMEN1KMT2ARXFP1 | |
| SCHEMBL27713744 | 0.84 | HTT (0.65) | ALDH1A1MAPTMEN1KMT2ARXFP1 | |
| SCHEMBL18852431 | 0.83 | ALDH1A1 (0.66) | ALDH1A1MAPTMEN1KMT2ARXFP1 | |
| SCHEMBL9886 | 0.83 | ALDH1A1 (0.85) | ALDH1A1MAPTMEN1KMT2ARXFP1 | |
| SCHEMBL19425986 | 0.83 | ALDH1A1 (0.85) | ALDH1A1MAPTMEN1KMT2ARXFP1 | |
| SCHEMBL1800895 | 0.83 | POLB (0.61) | ALDH1A1MAPTMEN1KMT2ARXFP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104119266-A | Method for preparing carbazole from phenolic compound | UNIV ZHEJIANG | 2014-10-29 | — | — | CN | claimed |
| CN-118326019-A | Mutant wells | 牛津纳米孔科技公开有限公司 | 2024-07-12 | — | — | CN | disclosed |
| CN-118326018-A | Mutant wells | 牛津纳米孔科技公开有限公司 | 2024-07-12 | — | — | CN | disclosed |
| CN-118272512-A | Mutant wells | 牛津纳米孔科技公开有限公司 | 2024-07-02 | — | — | CN | disclosed |
| CN-118256605-A | Mutant wells | 牛津纳米孔科技公开有限公司 | 2024-06-28 | — | — | CN | disclosed |
| CN-116514944-A | Mutant wells | 牛津纳米孔科技公开有限公司 | 2023-08-01 | — | — | CN | disclosed |
| CN-116377044-A | Methods and complexes for sequential translocation of two non-covalently bound complementary nucleic acid strands through a nanopore | 牛津纳米孔科技公开有限公司 | 2023-07-04 | — | — | CN | disclosed |
| CN-116334200-A | Method for determining polynucleotide characteristics using nanopores and complexes for use in the method | 牛津纳米孔科技公开有限公司 | 2023-06-27 | — | — | CN | disclosed |
| US-11420944-B2 | Voltage-dependent t-type calcium channel blocker | NIPPON CHEMIPHAR CO., LTD. (JP) | 2022-08-23 | — | — | US | disclosed |
| US-20190077767-A1 | VOLTAGE-DEPENDENT T-TYPE CALCIUM CHANNEL BLOCKER | NIPPON CHEMIPHAR CO., LTD. (JP) | 2019-03-14 | — | — | US | disclosed |
| WO-1993025518-A1 | NOVEL PROCESS FOR THE PREPARATION OF α-AMINOACYLANILIDES | MERCK & CO., INC. (US) | 1993-12-23 | — | — | WO | disclosed |
| EP-0488861-A1 | Process for the preparation of alkoxylated aromatic compounds | RHONE-POULENC CHIMIE (FR) | 1992-06-03 | — | — | EP | disclosed |
| EP-0455545-A1 | Process for the preparation of mono- or polyalkoxylated aromatic compounds | RHONE-POULENC CHIMIE (FR) | 1991-11-06 | — | — | EP | disclosed |
| EP-0434516-A2 | Process for the preparation of mono- or poly-alkoxylated aromatic compounds | RHONE-POULENC CHIMIE (FR) | 1991-06-26 | — | — | EP | disclosed |
| EP-0434517-A2 | Process for the preparation of mono- or poly-alkoxylated aromatic compounds | RHONE-POULENC CHIMIE (FR) | 1991-06-26 | — | — | EP | disclosed |
| US-4608081-A | SELECTIVITY AGAINST GRASSES | KANESHO COMPANY LIMITED (JP) | 1986-08-26 | — | — | US | disclosed |
| US-4435419-A | Method of treating depression using azabicyclohexanes | AMERICAN CYANAMID COMPANY (US) | 1984-03-06 | — | — | US | disclosed |
| US-4102924-A | REACTING ACYLAMINO-ARYLS WITH HALO-ARYLS | BAYER AKTIENGESELLSCHAFT (DE) | 1978-07-25 | — | — | US | disclosed |
| US-4017631-A | MICROBIOCIDES | JANSSEN PHARMACEUTICA N.V. (BE) | 1977-04-12 | — | — | US | disclosed |
| US-3991202-A | ANTIMICROBIALS | JANSSEN PHARMACEUTICA N.V. (BE) | 1976-11-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11420944-B2 | Voltage-dependent t-type calcium channel blocker | CACNA1I, CACNA1G, CACNA1E | ALDH1A1 3247/4885MAPT 574/4885MEN1 2133/4885 |
| US-20190077767-A1 | VOLTAGE-DEPENDENT T-TYPE CALCIUM CHANNEL BLOCKER | CACNA1I, CACNA1G, CACNA1E | ALDH1A1 3220/4885MAPT 707/4885MEN1 1995/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.